cureatr-x3
Sign In
Schedule a Demo
close
 

I want to learn more about: all topics

All Topics

Cureatr raises $13M for app 'custom-made' for DSRIP

Jake Behnke
Jake Behnke
June 25, 2015

Cureatr raises $13M for app 'custom-made' for DSRIP

by Jonathan LaMantia

June 25, 2015

Health technology startup Cureatr announced today that it has raised $13 million in Series B financing from a group led by Manhattan's Deerfield Investments. The company's software is used by providers including Montefiore, DaVita HealthCare Partners and the Visiting Nurse Service of New York. Its product allows for secure messaging between doctors and nurses. But the company believes its real value comes from an ability to help coordinate care among primary care doctors, specialists, and hospitals and other facilities.

This article originally appeared on Crain's New York Business. Click here to read the complete story.

Comments:

New call-to-action

Stay Connected
Cureatr COVID-19 Response

Topics:

Care Coordination

You Might Also Like:

Press Release

C-CDA Product Update

September 17, 2020

Telepharmacy

How to Define Telepharmacy to Patients

September 15, 2020

Telepharmacy

Remote Pharmacy: Understanding the Value of Telepharmacy for Patients

September 10, 2020
Solutions
Company
Connect With Us
About Cureatr

Cureatr is a comprehensive medication management (CMM) solutions company dedicated to repairing the United States’ $528 Billion, 275,000 deaths a year suboptimal medication management problem. We provide real-time, universal access to accurate medication data for over 265 Million patient and high-quality interventions by board certified telepharmacists. We have the expertise, resources, and technology to help you get the meds right and keep your patients out of the hospital.

footer-logo

© Cureatr 2020